Background illustration for clinical trials search

Paid Clinical Trials Madison

Discover 514 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 514

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

for

Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer,

Location: Madison WI, New York NY, Aurora CO, Boston MA,

Sponsor: I-Mab Biopharma US Limited

Sex: All

Age: 18+

Code: NCT04900818

Phase1, Recruiting

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

for

Prostate Cancer, Malignant Neoplasm of Prostate,

Location: Madison WI, Cleveland OH, New York NY

Sponsor: Case Comprehensive Cancer Center

Sex: Male

Age: 18+

Code: NCT06150417

Phase2, Recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

for

Advanced Malignant Solid Neoplasm,

Location: Madison WI, Chicago IL, City of Saint Peters MO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06311214

Phase2, Recruiting

SPEARHEAD-3 Pediatric Study

for

Synovial Sarcoma,

Location: Madison WI, St Louis MO, Cincinnati OH, Bethesda MD,

Sponsor: USWM CT, LLC

Sex: All

Age: 2 - 21

Code: NCT05642455

Phase1, Phase2, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for

AL Amyloidosis

Location: Madison WI, Milwaukee WI, Sheboygan WI, La Crosse WI,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase3, Recruiting

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

for

Solid Tumors, GI Cancer

Location: Madison WI, Washington DC, Baltimore MD, Durham NC,

Sponsor: Curegenix Inc.

Sex: All

Age: 18+

Code: NCT02675946

Phase1, Recruiting

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

for

Metastatic Colorectal Carcinoma,

Location: Madison WI, Chicago IL, Rochester MN, Grand Rapids MI,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT05863195

Phase3, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for

Melanoma

Location: Madison WI, Park Ridge IL, Hinsdale IL, Peoria IL,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

for

Cardiovascular Disorder, Classic Hodgkin Lymphoma,

Location: Madison WI, Springfield IL, Minneapolis MN,

Sponsor: Children's Oncology Group

Sex: All

Age: 7+

Code: NCT05705531

Recruiting

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

for

Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation,

Location: Madison WI, Chicago IL, Columbus OH, Lexington KY,

Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18+

Code: NCT05691465

Phase2, Recruiting

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

for

Metastatic Malignant Solid Neoplasm,

Location: Madison WI, Chicago IL, Columbus OH, Oklahoma City OK,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05687110

Phase1, Recruiting

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

for

Solid Tumors With HRAS Alterations,

Location: Madison WI, Iowa City IA, Rochester MN, St Louis MO,

Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06026410

Phase1, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for

Multiple Myeloma

Location: Madison WI, Chicago IL, Iowa City IA, Rochester MN,

Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase2, Recruiting

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

for

Prostate Cancer

Location: Madison WI, DeKalb IL, Geneva IL, Warrenville IL,

Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 21+

Code: NCT03151629

Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for

Peripheral T-Cell Lymphoma, Not Otherwise Specified,

Location: Madison WI, Chicago IL, Iowa City IA, Ann Arbor MI,

Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06561048

Phase3, Recruiting

Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial

for

Prostate Adenocarcinoma

Location: Madison WI, Chicago IL, Durham NC, Los Angeles CA

Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18+

Code: NCT06022822

Phase2, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for

Stage I Mixed Cell Type Kidney Wilms Tumor,

Location: Madison WI, Milwaukee WI, Park Ridge IL, Green Bay WI,

Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

for

Acute Myeloid Leukemia With FLT3/ITD Mutation,

Location: Madison WI, Columbus OH, Chapel Hill NC,

Sponsor: Uma Borate

Sex: All

Age: 18+

Code: NCT06222580

Phase1, Recruiting

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

for

Colorectal Carcinoma, Familial Adenomatous Polyposis

Location: Madison WI, Phoenix AZ

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06557733

Phase2, Recruiting

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

for

Angioimmunoblastic T-cell Lymphoma,

Location: Madison WI, DeKalb IL, Libertyville IL, Lake Forest IL,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT04803201

Phase2, Recruiting

Paid Clinical Trials Madison

Filter results

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

SPEARHEAD-3 Pediatric Study

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Interested in new trials?

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma